TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Redo Biosolutions AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
43,081
|
36,008
|
40,316 |
| Financial expenses |
389
|
728
|
460 |
| Earnings before taxes |
8,732
|
5,406
|
5,371 |
| Total assets |
54,014
|
50,628
|
49,471 |
| Current assets |
19,049
|
17,929
|
11,577 |
| Current liabilities |
10,228
|
10,176
|
23,420 |
| Equity capital |
40,455
|
35,377
|
18,841 |
| - share capital |
1,756
|
1,850
|
1,938 |
| Employees (average) | 16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
74.9%
|
69.9%
|
38.1% |
| Turnover per employee | 2,250 | ||
| Profit as a percentage of turnover |
20.3%
|
15.0%
|
13.3% |
| Return on assets (ROA) |
16.9%
|
12.1%
|
11.8% |
| Current ratio |
186.2%
|
176.2%
|
49.4% |
| Return on equity (ROE) |
21.6%
|
15.3%
|
28.5% |
| Change turnover |
8,913
|
-1,747
|
12,933 |
| Change turnover % |
26%
|
-5%
|
47% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.